🇺🇸 FDA
Patent

US 10286065

Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

granted A61KA61K2039/55561A61K31/215

Quick answer

US patent 10286065 (Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds) held by The Board of Regents of the University of Texas System expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/55561, A61K31/215, A61K31/24, A61K31/7056